BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17245312)

  • 1. [Hypocretins: involvement in the regulation of sleep-wakefulness cycle and pathogenesis of narcolepsy].
    Berezińska M; Zawilska JB
    Postepy Hig Med Dosw (Online); 2007; 61():1-12. PubMed ID: 17245312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding.
    Sutcliffe JG; de Lecea L
    J Neurosci Res; 2000 Oct; 62(2):161-8. PubMed ID: 11020209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypocretins and sleep.
    de Lecea L; Sutcliffe JG
    FEBS J; 2005 Nov; 272(22):5675-88. PubMed ID: 16279933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of hypocretins (orexins) in sleep regulation and narcolepsy.
    Taheri S; Zeitzer JM; Mignot E
    Annu Rev Neurosci; 2002; 25():283-313. PubMed ID: 12052911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter.
    Baumann CR; Bassetti CL
    Sleep Med Rev; 2005 Aug; 9(4):253-68. PubMed ID: 15979356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the hypocretinergic system in the integration of networks that dictate the states of arousal.
    Winsky-Sommerer R; Boutrel B; De Lecea L
    Drug News Perspect; 2003 Oct; 16(8):504-12. PubMed ID: 14668948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narcolepsy and the hypocretins.
    Wurtman RJ
    Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modulation by the hypocretinergic/orexinergic neurotransmission system in sleep-wakefulness cycle states].
    del Cid-Pellitero E; Garzón M
    Rev Neurol; 2007 Oct 16-31; 45(8):482-90. PubMed ID: 17948215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.
    Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M
    Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat.
    Beuckmann CT; Sinton CM; Williams SC; Richardson JA; Hammer RE; Sakurai T; Yanagisawa M
    J Neurosci; 2004 May; 24(18):4469-77. PubMed ID: 15128861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypocretin/orexin system in health and disease.
    Nishino S
    Biol Psychiatry; 2003 Jul; 54(2):87-95. PubMed ID: 12873797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocretin/orexin, sleep and narcolepsy.
    Hungs M; Mignot E
    Bioessays; 2001 May; 23(5):397-408. PubMed ID: 11340621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocretins (orexins) and sleep-wake disorders.
    Baumann CR; Bassetti CL
    Lancet Neurol; 2005 Oct; 4(10):673-82. PubMed ID: 16168936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of the hypocretin/orexins in the regulation of sleep and wakefulness.
    Terao A; Haruyama T; Kimura K
    Jpn J Vet Res; 2008 Jan; 55(2-3):75-83. PubMed ID: 18318109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sleep-wake cycle, the hypocretin/orexin system and narcolepsy: advances from preclinical research to treatment.
    Arias-Carrión O; Bradbury M
    CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):232-4. PubMed ID: 19689304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The neurotransmitter, hypocretin. An overview].
    Baumann C; Bassetti C
    Nervenarzt; 2004 Apr; 75(4):317-23. PubMed ID: 15088087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic state signalling through central hypocretin/orexin neurons.
    Burdakov D; Alexopoulos H
    J Cell Mol Med; 2005; 9(4):795-803. PubMed ID: 16364191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats.
    Zhang S; Lin L; Kaur S; Thankachan S; Blanco-Centurion C; Yanagisawa M; Mignot E; Shiromani PJ
    Neuroscience; 2007 Aug; 148(1):34-43. PubMed ID: 17618058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities.
    Yoshida Y; Fujiki N; Nakajima T; Ripley B; Matsumura H; Yoneda H; Mignot E; Nishino S
    Eur J Neurosci; 2001 Oct; 14(7):1075-81. PubMed ID: 11683899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.